| |
| | Suboxone (Buprenorphine) |
 | | The subject is Suboxone®, the first legal opioid substitution treatment available by prescription without attachment to a special clinic since the passage of the earliest anti-narcotics laws (e.g., the Harrison act). |
 | | The Suboxone® product is actually just a sublingual formulation of an extremely high dose of buprenorphine, a partial-agonist opioid available in the U.S., at far lower does, as an injectable analgesic, which goes by the brand name Buprenex®, and is also available in generic form. |
 | | The Suboxone® product is formulated for sublingual administration and is combined with the pure opioid antagonist naloxone, in an attempt to deter intravenous misuse of the product: sublingually absorbed naloxone is without signficant effect, but if it is injected, it will cause an immediate and extremely intense withdrawal reaction in opioid-dependent persons. |
| www.etfrc.com /suboxone.htm (1349 words) |
|